NKT2152
Showing 1 - 2 of 2
ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)
Not yet recruiting
- ccRCC
- +20 more
- NKT2152
- +2 more
- (no location specified)
Jul 6, 2023
ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)
Recruiting
- ccRCC
- +9 more
- Oral NKT2152
-
Scottsdale, Arizona
- +6 more
Oct 17, 2022